H-Gly-Gly-Gly-OH

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.
H-Gly-Gly-Gly-OH(CAS 556-33-2)

CAT No: OPO-029

CAS No:556-33-2

Synonyms/Alias:556-33-2;Glycylglycylglycine;Triglycine;Glycyl-glycyl-glycine;H-Gly-Gly-Gly-OH;Gly-Gly-Gly;Diglycylglycine;N-(N-Glycylglycyl)glycine;Glycine, glycylglycyl-;GlyGlyGly;2-(2-(2-Aminoacetamido)acetamido)acetic acid;2-[[2-[(2-aminoacetyl)amino]acetyl]amino]acetic acid;Glycine, N-(N-glycylglycyl)-;UNII-CVK73ZDQ8B;MFCD00036223;CHEBI:63961;(Gly)3;EINECS 209-122-0;NSC 46707;NSC-46707;CVK73ZDQ8B;TRIGLYCINE [USP-RS];CHEMBL54278;DTXSID80204140;Gly-Gly-Gly-OH;TRIGLYCINE (USP-RS);[2-(2-Amino-acetylamino)-acetylamino]-acetic acid;2-[[2-[(2-Aminoacetyl)amino]acetyl]amino]acetic Acid (Triglycine);2-[2-(2-aminoacetamido)acetamido]acetic acid;2-((2-((2-aminoacetyl)amino)acetyl)amino)acetic acid;2-((2-((2-azaniumylacetyl)amino)acetyl)amino)acetate;2-[[2-[(2-azaniumylacetyl)amino]acetyl]amino]acetate;Glycylpeptide;2-({2-[(2-AMINOACETYL)AMINO]ACETYL}AMINO)ACETIC ACID;diglycyl-glycine;GGG peptide;Triglycine (van);NSC46707;N(NGlycylglycyl)glycine;Maybridge1_006812;SCHEMBL98565;N-(N-GLYCYLGLYCYL)-Glycine;HMS560N14;DTXCID80126631;Glycine, N(Nglycylglycyl) (8CI);OGG-3061;BDBM50188484;Glycine, N-(N-glycylglycyl)-(8CI);AKOS005207234;CS-W015952;DS-7430;FG39666;HY-W015236;BP-31100;Glycine, N(Nglycylglycyl) (8CI)(9CI);SY025319;Glycine, N-(N-glycylglycyl)-(8CI)(9CI);G0126;Gly-Gly-Gly, BioUltra, >=99.0% (NT);NS00033358;Glycine, N-(N-glycylglycyl)- (8CI)(9CI);(([(Aminoacetyl)amino]acetyl)amino)acetic acid;3,6-Diazaoctanoic acid, 8-amino-4,7-dioxo-;EN300-176110;F17230;Glycylglycylglycine, 98+% (H-Gly-Gly-Gly-OH);(([(Aminoacetyl)amino]acetyl)amino)acetic acid #;Q27132936;Triglycine, United States Pharmacopeia (USP) Reference Standard;

Chemical Name:2-[[2-[(2-aminoacetyl)amino]acetyl]amino]acetic acid

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C6H11N3O4
M.W/Mr.
189.17
Sequence
One Letter Code:GGG
Three Letter Code:H-Gly-Gly-Gly-OH
InChI
InChI=1S/C6H11N3O4/c7-1-4(10)8-2-5(11)9-3-6(12)13/h1-3,7H2,(H,8,10)(H,9,11)(H,12,13)
InChI Key
XKUKSGPZAADMRA-UHFFFAOYSA-N
Canonical SMILES
C(C(=O)NCC(=O)NCC(=O)O)N

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Peptide CDMOPeptide Modification ServicesCustom Conjugation ServicePeptide Synthesis ServicescGMP Peptide ServicePeptide Analysis ServicesEpitope Mapping ServicesPeptide Nucleic Acids Synthesis
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers